Paid

The FDA cleared The Bigfoot Unity AI Diabetes Management System by Bigfoot Biomedical for T1D & T2D management in patients of 12 or older.  

Older adults with prediabetes or diabetes experienced faster physical functional decline and disability progression.

The use of insulin to treat type 2 diabetes patients is growing, but does its risk for hypoglycemia impact cardiovascular health?

A systematic review and meta-analysis of randomized controlled trials examines how some inflammatory markers may be affected by physical activity.

GLP1 RA and SGLT-2 were compared to evaluate coronary health disease reduction in patients with type 2 diabetes.

Researchers sought to identify the prevalence of metabolic syndrome in patients with type 1 diabetes and its relationship to diabetic complication development. 

Could adding a SGLT-2 inhibitor to a closed-loop automated insulin delivery reduce the need for carbohydrate counting? 

Long-acting insulins seem to be the best choice for elderly patients diagnosed with type 2 diabetes.

Data analysis suggests that patients with prediabetes have a similar risk for declines in brain function to patients diagnosed with diabetes.

Intensive glucose-lowering techniques can have positive outcomes in patients >65 years.